From Alec Cawley
You would not expect the polypill to “reduce the costs of health insurers or state-run health services” other than for an initial period (5 July, p 3).
We all have to die some day, and Alzheimer’s disease and cancer are probably more expensive ways to die than a quick heart attack. The pay-off would be in longer lives, not money.
Newbury, Berkshire, UK
